Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis | 3 | 2023 | 278 | 1.950 |
Why?
|
| Polymyositis | 2 | 2022 | 77 | 1.420 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2023 | 552 | 1.070 |
Why?
|
| HMGB1 Protein | 2 | 2024 | 141 | 0.750 |
Why?
|
| Imidazoles | 2 | 2024 | 1174 | 0.550 |
Why?
|
| Mononeuropathies | 1 | 2016 | 13 | 0.540 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2022 | 1797 | 0.530 |
Why?
|
| Sialadenitis | 1 | 2016 | 45 | 0.520 |
Why?
|
| Cryoglobulinemia | 1 | 2016 | 84 | 0.510 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 935 | 0.500 |
Why?
|
| Hemorrhagic Disorders | 1 | 2015 | 34 | 0.490 |
Why?
|
| Indoles | 2 | 2024 | 1834 | 0.470 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1561 | 0.440 |
Why?
|
| Immunity, Innate | 1 | 2024 | 3080 | 0.390 |
Why?
|
| Vasculitis | 1 | 2016 | 524 | 0.390 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 549 | 0.370 |
Why?
|
| Muscle Weakness | 2 | 2023 | 415 | 0.330 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 4984 | 0.300 |
Why?
|
| Antirheumatic Agents | 3 | 2023 | 1374 | 0.270 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.240 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4572 | 0.230 |
Why?
|
| Malus | 1 | 2023 | 51 | 0.210 |
Why?
|
| Interleukin-13 | 1 | 2024 | 392 | 0.200 |
Why?
|
| Perforin | 1 | 2022 | 169 | 0.190 |
Why?
|
| Fas Ligand Protein | 1 | 2022 | 218 | 0.190 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3763 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2024 | 635 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 507 | 0.170 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2022 | 167 | 0.170 |
Why?
|
| Granzymes | 1 | 2022 | 279 | 0.170 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 335 | 0.160 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 736 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 598 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2015 | 3431 | 0.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 520 | 0.160 |
Why?
|
| Methotrexate | 2 | 2023 | 1722 | 0.150 |
Why?
|
| Prednisolone | 2 | 2016 | 327 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 9558 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 4642 | 0.150 |
Why?
|
| Mice | 7 | 2024 | 82045 | 0.140 |
Why?
|
| Lung | 3 | 2024 | 10090 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2022 | 641 | 0.140 |
Why?
|
| Submandibular Gland | 1 | 2016 | 85 | 0.130 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2016 | 12 | 0.130 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2016 | 42 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 22365 | 0.130 |
Why?
|
| Animals | 8 | 2024 | 169418 | 0.130 |
Why?
|
| Glucocorticoids | 2 | 2023 | 2170 | 0.130 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 158 | 0.120 |
Why?
|
| Inflammation | 3 | 2023 | 10865 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2024 | 4180 | 0.110 |
Why?
|
| Creatinine | 1 | 2020 | 1915 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 1183 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 1977 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2022 | 1892 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2016 | 598 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 2008 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1840 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3854 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 2173 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3246 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4728 | 0.080 |
Why?
|
| Humans | 15 | 2024 | 768451 | 0.070 |
Why?
|
| Biopsy | 1 | 2020 | 6816 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19041 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11930 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2293 | 0.050 |
Why?
|
| Male | 7 | 2024 | 364781 | 0.050 |
Why?
|
| Myofibroblasts | 1 | 2024 | 232 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2024 | 23638 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 418 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2024 | 1158 | 0.040 |
Why?
|
| Middle Aged | 6 | 2024 | 223418 | 0.040 |
Why?
|
| Lung Injury | 1 | 2024 | 435 | 0.040 |
Why?
|
| Female | 6 | 2024 | 396943 | 0.040 |
Why?
|
| Itraconazole | 1 | 2016 | 43 | 0.030 |
Why?
|
| Remission Induction | 1 | 2021 | 2408 | 0.030 |
Why?
|
| Leptin | 1 | 2023 | 1598 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81834 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18388 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 171520 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3234 | 0.030 |
Why?
|
| Pneumonia | 1 | 2024 | 2162 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 510 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2016 | 761 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3901 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 65409 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14480 | 0.020 |
Why?
|
| Cytokines | 1 | 2023 | 7449 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 13065 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 13026 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 30179 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54914 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59680 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_